Review of Current Guidelines on the Care of Postherpetic Neuralgia

References

• . Johnson R W. Herpes zoster and postherpetic neuralgia. Expert Rev Vaccines. 2010; 9( 3 suppl):21–26
   PubMed Web of Science ®Google Scholar
• . Sampathkumar P, Drage LA, Martin DP. Herpes zoster (shingles) and postherpetic neuralgia. Mayo Clin Proc. 2009; 84(3):274–280
   PubMed Web of Science ®Google Scholar
• . Civen R, Chaves SS, Jumaan A, . The incidence and clinical characteristics of herpes zoster among children and adolescents after implementation of varicella vaccination. Pediatr Infect Dis J. 2009; 28(11):954–959
   PubMed Web of Science ®Google Scholar
• . Insinga RP, Itzler RF, Pellissier JM, Saddier P, Nikas AA. The incidence of herpes zoster in a United States administrative database. J Gen Intern Med. 2005; 20(8):748–753
   PubMed Web of Science ®Google Scholar
• . Ferreira M, Sanches M, Teixeira M, Guerra M, Selores M. Persistent varicella as the initial manifestation of systemic lymphoma. Dermatol Online J. 2008; 14(2):24
   PubMedGoogle Scholar
• . Fuks L, Shitrit D, Fox BD, . Herpes zoster after lung transplantation: Incidence, timing, and outcome. Ann Thorac Surg. 2009; 87(2):423–426
   PubMed Web of Science ®Google Scholar
• . Shin BS, Na CH, Song IG, Choi KC. A case of human immunodeficiency virus infection initially presented with disseminated herpes zoster. Ann Dermatol. 2010; 22(2):199–202
   PubMed Web of Science ®Google Scholar
• . Argoff CE, Katz N, Backonja M. Treatment of postherpetic neuralgia: A review of therapeutic options. J Pain Symptom Manage. 2004; 28(4):396–411
   PubMed Web of Science ®Google Scholar
• . Edmunds WJ, Brisson M, Rose JD. The epidemiology of herpes zoster and potential cost-effectiveness of vaccination in England and Wales. Vaccine. 2001; 19(23–24):3076–3090
   PubMed Web of Science ®Google Scholar
• . Ragozzino MW, Melton LJ 3rd, Kurland LT, Chu CP, Perry HO. Population-based study of herpes zoster and its sequelae. Medicine (Baltimore). 1982; 61(5):310–316
   PubMed Web of Science ®Google Scholar
• . Dworkin RH, Portenoy RK. Pain and its persistence in herpes zoster. Pain. 1996; 67(2–3):241–251
   PubMed Web of Science ®Google Scholar
• . Opstelten W, Mauritz JW, de Wit NJ, van Wijck AJ, Stalman WA, van Essen GA. Herpes zoster and postherpetic neuralgia: Incidence and risk indicators using a general practice research database. Fam Pract. 2002; 19(5):471–475
   PubMed Web of Science ®Google Scholar
• . Woolf CJ, Max MB. Mechanism-based pain diagnosis: Issues for analgesic drug development. Anesthesiology. 2001; 95(1): 241–249
   PubMed Web of Science ®Google Scholar
• . Woolf CJ, Costigan M. Transcriptional and posttranslational plasticity and the generation of inflammatory pain. Proc Natl Acad Sci U S A. 1999; 96(14):7723–7730
   PubMed Web of Science ®Google Scholar
• . Beydoun A, Backonja MM. Mechanistic stratification of antineuralgic agents. J Pain Symptom Manage. 2003; 25( 5 suppl):S18–S30
   PubMed Web of Science ®Google Scholar
• . Gottschalk A, Smith DS. New concepts in acute pain therapy: Preemptive analgesia. Am Fam Physician. 2001; 63(10):1979–1984
   PubMed Web of Science ®Google Scholar
• . Dworkin RH, O'Connor AB, Backonja M, . Pharmacologic management of neuropathic pain: Evidence-based recommendations. Pain. 2007; 132(3):237–251
   PubMed Web of Science ®Google Scholar
• . Attal N, Cruccu G, Baron R, . EFNS guidelines on the pharmacological treatment of neuropathic pain: 2010 revision. Eur J Neurol. 2010; 17(9):e1113–e1188
   PubMed Web of Science ®Google Scholar
• . Dubinsky RM, Kabbani H, El-Chami Z, Boutwell C, Ali H; Quality Standards Subcommittee of the American Academy of Neurology. Practice parameter: treatment of postherpetic neuralgia: An evidence-based report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology. 2004; 63(6): 959–965
   PubMed Web of Science ®Google Scholar
• . Dworkin RH, O'Connor AB, Audette J, . Recommendations for the pharmacological management of neuropathic pain: An overview and literature update. Mayo Clin Proc. 2010; 85( 3 suppl):S3–S14
   PubMed Web of Science ®Google Scholar
• . Oxman MN, Levin MJ; Shingles Prevention Study Group. Vaccination against herpes zoster and postherpetic neuralgia. J Infect Dis. 2008; 197( suppl 2):S228–S236
   PubMed Web of Science ®Google Scholar
• . Simberkoff MS, Arbeit RD, Johnson GR, . Safety of herpes zoster vaccine in the shingles prevention study: A randomized trial. Ann Intern Med. 2010; 152(9):545–554
   PubMed Web of Science ®Google Scholar
• . Chen N, Li Q, Zhang Y, Zhou M, Zhou D, He L. Vaccination for preventing postherpetic neuralgia. Cochrane Database Syst Rev. 2011; 3:CD007795
   Google Scholar
• . Rothberg MB, Virapongse A, Smith KJ. Cost-effectiveness of a vaccine to prevent herpes zoster and postherpetic neuralgia in older adults. Clin Infect Dis. 2007; 44(10):1280–1288
   PubMed Web of Science ®Google Scholar
• . National Center for Immunization and Respiratory Diseases. General recommendations on immunization: Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep. 2011; 60(2):1–64
   Google Scholar
• . Whitley RJ, Weiss H, Gnann JW Jr, . Acyclovir with and without prednisone for the treatment of herpes zoster. A randomized, placebo-controlled trial. The National Institute of Allergy and Infectious Diseases Collaborative Antiviral Study Group. Ann Intern Med. 1996; 125(5):376–383
   PubMed Web of Science ®Google Scholar
• . Wood MJ, Johnson RW, McKendrick MW, Taylor J, Mandal BK, Crooks J. A randomized trial of acyclovir for 7 days or 21 days with and without prednisolone for treatment of acute herpes zoster. N Engl J Med. 1994; 330(13):896–900
   PubMed Web of Science ®Google Scholar
• . Hempenstall K, Nurmikko TJ, Johnson RW, A'Hern RP, Rice AS. Analgesic therapy in postherpetic neuralgia: A quantitative systematic review. PLoS Med. 2005; 2(7):e164
   Web of Science ®Google Scholar
• . Saarto T, Wiffen PJ. Antidepressants for neuropathic pain. Cochrane Database Syst Rev. 2007;(4):CD005454
   Google Scholar
• . Finnerup NB, Otto M, McQuay HJ, Jensen TS, Sindrup SH. Algorithm for neuropathic pain treatment: An evidence based proposal. Pain. 2005; 118(3):289–305
   PubMed Web of Science ®Google Scholar
• . Sindrup SH, Otto M, Finnerup NB, Jensen TS. Antidepressants in the treatment of neuropathic pain. Basic Clin Pharmacol Toxicol. 2005; 96(6):399–409
   PubMed Web of Science ®Google Scholar
• . Cohen HW, Gibson G, Alderman MH. Excess risk of myocardial infarction in patients treated with antidepressant medications: Association with use of tricyclic agents. Am J Med. 2000; 108(1):2–8
   PubMed Web of Science ®Google Scholar
• . Ray WA, Meredith S, Thapa PB, Hall K, Murray KT. Cyclic antidepressants and the risk of sudden cardiac death. Clin Pharmacol Ther. 2004; 75(3):234–241
   PubMed Web of Science ®Google Scholar
• . Tata LJ, West J, Smith C, . General population based study of the impact of tricyclic and selective serotonin reuptake inhibitor antidepressants on the risk of acute myocardial infarction. Heart. 2005; 91(4):465–471
   PubMed Web of Science ®Google Scholar
• . Max MB, Lynch SA, Muir J, Shoaf SE, Smoller B, Dubner R. Effects of desipramine, amitriptyline, and fluoxetine on pain in diabetic neuropathy. N Engl J Med. 1992; 326(19):1250–1256
   PubMed Web of Science ®Google Scholar
• . Watson CP, Vernich L, Chipman M, Reed K. Nortriptyline versus amitriptyline in postherpetic neuralgia: A randomized trial. Neurology. 1998; 51(4):1166–1171
   PubMed Web of Science ®Google Scholar
• . Moore RA, Wiffen PJ, Derry S, McQuay HJ. Gabapentin for chronic neuropathic pain and fibromyalgia in adults. Cochrane Database Syst Rev. 2011; 3:CD007938
   PubMed Web of Science ®Google Scholar
• . Moore RA, Straube S, Wiffen PJ, Derry S, McQuay HJ. Pregabalin for acute and chronic pain in adults. Cochrane Database Syst Rev. 2009; 3:CD007076
   PubMed Web of Science ®Google Scholar
• . Freeman R, Durso-Decruz E, Emir B. Efficacy, safety, and tolerability of pregabalin treatment for painful diabetic peripheral neuropathy: Findings from seven randomized, controlled trials across a range of doses. Diabetes Care. 2008; 31(7):1448–1454
   PubMed Web of Science ®Google Scholar
• . Watson CP, Babul N. Efficacy of oxycodone in neuropathic pain: A randomized trial in postherpetic neuralgia. Neurology. 1998; 50(6):1837–1841
   PubMed Web of Science ®Google Scholar
• . Raja SN, Haythornthwaite JA, Pappagallo M, . Opioids versus antidepressants in postherpetic neuralgia: A randomized, placebo-controlled trial. Neurology. 2002; 59(7):1015–1021
   PubMed Web of Science ®Google Scholar
• . Boureau F, Legallicier P, Kabir-Ahmadi M. Tramadol in post-herpetic neuralgia: A randomized, double-blind, placebo-controlled trial. Pain. 2003; 104(1–2):323–331
   PubMed Web of Science ®Google Scholar
• . Lunn MP, Hughes RA, Wiffen PJ. Duloxetine for treating painful neuropathy or chronic pain. Cochrane Database Syst Rev. 2009; 4:CD007115
   Google Scholar
• . Raskin J, Smith TR, Wong K, . Duloxetine versus routine care in the long-term management of diabetic peripheral neuropathic pain. J Palliat Med. 2006; 9(1):29–40
   PubMed Web of Science ®Google Scholar
• . Wernicke JF, Pritchett YL, D'Souza DN, . A randomized controlled trial of duloxetine in diabetic peripheral neuropathic pain. Neurology. 2006; 67(8):1411–1420
   PubMed Web of Science ®Google Scholar
• . Sang CN, Booher S, Gilron I, Parada S, Max MB. Dextromethorphan and memantine in painful diabetic neuropathy and postherpetic neuralgia: Efficacy and dose-response trials. Anesthesiology. 2002; 96(5):1053–1061
   PubMed Web of Science ®Google Scholar
• . Wallace MS, Rowbotham MC, Katz NP, . A randomized, double-blind, placebo-controlled trial of a glycine antagonist in neuropathic pain. Neurology. 2002; 59(11):1694–1700
   PubMed Web of Science ®Google Scholar
• . Max MB, Schafer SC, Culnane M, Smoller B, Dubner R, Gracely RH. Amitriptyline, but not lorazepam, relieves postherpetic neuralgia. Neurology. 1988; 38(9):1427–1432
   PubMed Web of Science ®Google Scholar
• . Baron R, Tolle TR, Gockel U, Brosz M, Freynhagen R. A cross-sectional cohort survey in 2100 patients with painful diabetic neuropathy and postherpetic neuralgia: Differences in demographic data and sensory symptoms. Pain. 2009; 146(1–2):34–40
   PubMed Web of Science ®Google Scholar
• . Baron R, Mayoral V, Leijon G, Binder A, Steigerwald I, Serpell M. 5% lidocaine medicated plaster versus pregabalin in post-herpetic neuralgia and diabetic polyneuropathy: An open-label, non-inferiority two-stage RCT study. Curr Med Res Opin. 2009; 25(7):1663–1676
   PubMed Web of Science ®Google Scholar
• . Binder A, Bruxelle J, Rogers P, Hans G, Bosl I, Baron R. Topical 5% lidocaine (lignocaine) medicated plaster treatment for post-herpetic neuralgia: Results of a double-blind, placebo-controlled, multinational efficacy and safety trial. Clin Drug Investig. 2009; 29(6): 393–408
   PubMed Web of Science ®Google Scholar
• . Rehm S, Binder A, Baron R. Post-herpetic neuralgia: 5% lidocaine medicated plaster, pregabalin, or a combination of both? A randomized, open, clinical effectiveness study. Curr Med Res Opin. 2010; 26(7):1607–1619
   PubMed Web of Science ®Google Scholar
• . Hans G, Sabatowski R, Binder A, Boesl I, Rogers P, Baron R. efficacy and tolerability of a 5% lidocaine medicated plaster for the topical treatment of post-herpetic neuralgia: Results of a long-term study. Curr Med Res Opin. 2009; 25(5):1295–1305
   PubMed Web of Science ®Google Scholar
• . Baron R, Mayoral V, Leijon G, Binder A, Steigerwald I, Serpell M. Efficacy and safety of 5% lidocaine (lignocaine) medicated plaster in comparison with pregabalin in patients with postherpetic neuralgia and diabetic polyneuropathy: Interim analysis from an open-label, two-stage adaptive, randomized, controlled trial. Clin Drug Investig. 2009; 29(4):231–241
   PubMed Web of Science ®Google Scholar
• . Campbell BJ, Rowbotham M, Davies PS, Jacob P 3rd, Benowitz NL. Systemic absorption of topical lidocaine in normal volunteers, patients with post-herpetic neuralgia, and patients with acute herpes zoster. J Pharm Sci. 2002; 91(5):1343–1350
   PubMed Web of Science ®Google Scholar
• . Gammaitoni AR, Davis M W. Pharmacokinetics and tolerability of lidocaine patch 5% with extended dosing. Ann Pharmacother. 2002; 36(2):236–240
   PubMed Web of Science ®Google Scholar
• . Gammaitoni AR, Alvarez NA, Galer BS. Safety and tolerability of the lidocaine patch 5%, a targeted peripheral analgesic: A review of the literature. J Clin Pharmacol. 2003; 43(2):111–117
   PubMed Web of Science ®Google Scholar
• . Bernstein JE, Korman NJ, Bickers DR, Dahl MV, Millikan LE. Topical capsaicin treatment of chronic postherpetic neuralgia. J Am Acad Dermatol. 1989; 21(2 pt 1):265–270
   PubMed Web of Science ®Google Scholar
• . Watson CP, Tyler KL, Bickers DR, Millikan LE, Smith S, Coleman E. A randomized vehicle-controlled trial of topical capsaicin in the treatment of postherpetic neuralgia. Clin Ther. 1993; 15(3):510–526
   PubMed Web of Science ®Google Scholar
• . Backonja M, Wallace MS, Blonsky ER, ; NGX-4010 C116 Study Group. NGX-4010, a high-concentration capsaicin patch, for the treatment of postherpetic neuralgia: A randomised, double-blind study. Lancet Neurol. 2008; 7(12):1106–1112
   PubMed Web of Science ®Google Scholar
• . Backonja MM, Malan TP, Vanhove GF, Tobias JK. NGX-4010, a high-concentration capsaicin patch, for the treatment of postherpetic neuralgia: A randomized, double-blind, controlled study with an open-label extension. Pain Med. 2010; 11(4):600–608
   PubMed Web of Science ®Google Scholar
• . Derry S, Lloyd R, Moore RA, McQuay HJ. Topical capsaicin for chronic neuropathic pain in adults. Cochrane Database Syst Rev. 2009; 4:CD007393
   PubMed Web of Science ®Google Scholar
• . Noto C, Pappagallo M, Szallasi A. NGX-4010, a high-concentration capsaicin dermal patch for lasting relief of peripheral neuropathic pain. Curr Opin Investig Drugs. 2009; 10(7):702–710
   PubMedGoogle Scholar
• . US Food and Drug Administration. FDA approves new drug treatment for long-term pain relief after shingles attacks. http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/2009/ucm191003.htm. Accessed June 30, 2011
   Google Scholar
• . Babbar S, Marier JF, Mouksassi MS, . Pharmacokinetic analysis of capsaicin after topical administration of a high-concentration capsaicin patch to patients with peripheral neuropathic pain. Ther Drug Monit. 2009; 31(4):502–510
   PubMed Web of Science ®Google Scholar
• . Mason L, Moore RA, Derry S, Edwards JE, McQuay HJ. Systematic review of topical capsaicin for the treatment of chronic pain. BMJ. 2004; 328(7446):991
   PubMed Web of Science ®Google Scholar
• . Simpson DM, Brown S, Tobias J; NGX-4010C107 Study Group. Controlled trial of high-concentration capsaicin patch for treatment of painful HIV neuropathy. Neurology. 2008; 70(24):2305–2313
   PubMed Web of Science ®Google Scholar
• . Simpson DM, Gazda S, Brown S, ; NGX-4010 C118 Study Group. Long-term safety of NGX-4010, a high-concentration capsaicin patch, in patients with peripheral neuropathic pain. J Pain Symptom Manage. 2010; 39(6):1053–1064
   PubMed Web of Science ®Google Scholar
• . Qutenza® (capsaicin 8% patch) [package insert]. San Mateo, CA: NeurogesX, Inc.; 2009
   Google Scholar
• . Gilron I, Bailey JM, Tu D, Holden RR, Jackson AC, Houlden RL. Nortriptyline and gabapentin, alone and in combination for neuropathic pain: A double-blind, randomised controlled crossover trial. Lancet. 2009; 374(9697):1252–1261
   PubMed Web of Science ®Google Scholar
• . Gilron I, Bailey JM, Tu D, Holden RR, Weaver DF, Houlden RL. Morphine, gabapentin, or their combination for neuropathic pain. N Engl J Med. 2005; 352(13):1324–1334
   PubMed Web of Science ®Google Scholar
• . Ruiz Huete C, Bermejo PE. Botulinum toxin type A in the treatment of neuropathic pain in a case of postherpetic neuralgia [in Spanish]. Neurologia. 2008; 23(4):259–262
   PubMed Web of Science ®Google Scholar
• . Sotiriou E, Apalla Z, Panagiotidou D, Ioannidis D. Severe post-herpetic neuralgia successfully treated with botulinum toxin A: Three case reports. Acta Derm Venereol. 2009; 89(2):214–215
   PubMed Web of Science ®Google Scholar
• . Ranoux D, Attal N, Morain F, Bouhassira D. Botulinum toxin type A induces direct analgesic effects in chronic neuropathic pain. Ann Neurol. 2008; 64(3):274–283
   PubMed Web of Science ®Google Scholar
• . Xiao L, Mackey S, Hui H, Xong D, Zhang Q, Zhang D. Subcutaneous injection of botulinum toxin a is beneficial in postherpetic neuralgia. Pain Med. 2010; 11(12):1827–1833
   PubMed Web of Science ®Google Scholar
• . Argoff CE. A focused review on the use of botulinum toxins for neuropathic pain. Clin J Pain. 2002; 18( 6 suppl):S177–S181
   PubMed Web of Science ®Google Scholar
• . van Wijck AJ, Wallace M, Mekhail N, van Kleef M. Evidence-based interventional pain medicine according to clinical diagnoses. 17. Herpes zoster and post-herpetic neuralgia. Pain Pract. 2011; 11(1):88–97
   PubMed Web of Science ®Google Scholar
• . Ji G, Niu J, Shi Y, Hou L, Lu Y, Xiong L. The effectiveness of repetitive paravertebral injections with local anesthetics and steroids for the prevention of postherpetic neuralgia in patients with acute herpes zoster. Anesth Analg. 2009; 109(5):1651–1655
   PubMed Web of Science ®Google Scholar
• . van Wijck AJ, Opstelten W, Moons KG, . The PINE study of epidural steroids and local anaesthetics to prevent postherpetic neuralgia: A randomised controlled trial. Lancet. 2006; 367(9506):219–224
   PubMed Web of Science ®Google Scholar
• . Dureja GP, Usmani H, Khan M, Tahseen M, Jamal A. efficacy of intrathecal midazolam with or without epidural methylprednisolone for management of post-herpetic neuralgia involving lumbosacral dermatomes. Pain Physician. 2010; 13(3):213–221
   PubMed Web of Science ®Google Scholar
• . Kotani N, Kushikata T, Hashimoto H, . Intrathecal methylprednisolone for intractable postherpetic neuralgia. N Engl J Med. 2000; 343(21):1514–1519
   PubMed Web of Science ®Google Scholar
• . Cheville AL, Sloan JA, Northfelt DW, . Use of a lidocaine patch in the management of postsurgical neuropathic pain in patients with cancer: A phase III double-blind crossover study (N01CB). Support Care Cancer. 2009; 17(4):451–460
   PubMed Web of Science ®Google Scholar
• . Harke H, Gretenkort P, Ladleif HU, Koester P, Rahman S. Spinal cord stimulation in postherpetic neuralgia and in acute herpes zoster pain. Anesth Analg. 2002; 94(3):694–700
   PubMed Web of Science ®Google Scholar
• . Petersen KL, Rowbotham MC. Relief of post-herpetic neuralgia by surgical removal of painful skin: 5 years later. Pain. 2007; 131(1–2):214–218
   PubMed Web of Science ®Google Scholar